Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Spotlight
GLP-1s
Interviews
FDA
Strategy
Generics
Biosimilars
Value Added Medicines
Business
Deals
Earnings
Manufacturing
Policy & Regulation
Regulatory Landscape
Drug Pricing
IP & Litigation
Tools & Trackers
What's Next?
Who's Hired?
UK Pricing Tracker
Company Rankings
Podcasts
Conference Coverage
Partner Insights
Generics Bulletin Perspectives
Exploring market-shifting topics for the off-patent sector.
View
Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Stada And Xbrane Receive MHRA Nod For Ranibizumab
Ximluci Biosimilar Rival To Lucentis Will Be Launched ‘During 2023’
Jan 18 2023
•
By
David Wallace
The MHRA has approved Ximluci in Great Britain • Source: Shutterstock
More from Products
More from Generics Bulletin
